Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy program
Eun Kyoung Chung1, Cole B Beeler1, Eva W Muloma1
1Eun Kyoung Chung, Pharm.D., Ph.D., is Assistant Professor, Clinical Pharmacy/Pharmacotherapy, Department of Pharmacy, Kyung Hee University College of Pharmacy, Seoul, South Korea; at the time of writing she was a graduate student, Department of Pharmacy Practice, Purdue University College of Pharmacy, West Lafeyette, IN. Cole B. Beeler, M.D., is Infectious Diseases Fellow, Indiana University School of Medicine, Indianapolis; at the time of writing he was Chief Internal Medical Resident, Eskenazi Health (formerly Wishard Health Services), Indianapolis. Eva W. Muloma, M.D., is Infectious Diseases Physician, Indiana University Medical Group, and Co-Director, Outpatient Parenteral Antimicrobial Therapy (OPAT) Program, Eskenazi Health. Danielle Osterholzer, M.D., is Infectious Diseases Faculty, Hurley Medical Center, Flint, MI; at the time of writing she was Assistant Clinical Professor of Medicine and Pediatrics, Division of Infectious Diseases, Indiana University School of Medicine, and Section Chief of Infectious Diseases, Eskenazi Health. Kendra M. Damer, Pharm.D., is Associate Professor, Department of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, Indianapolis; at the time of writing she was Assistant Professor of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, and Infectious Diseases Clinical Pharmacy Specialist, Eskenazi Health. Sharon M. Erdman, Pharm.D., is Clinical Professor, Department of Pharmacy Practice, Purdue University College of Pharmacy, and Infectious Diseases Clinical Pharmacist and Co-Director, OPAT Program, Eskenazi Health.
A pharmacist-managed outpatient parenteral antimicrobial therapy (OPAT) program was implemented to improve patient outcomes. This structured monitoring program minimized adverse events associated with infection treatment.
Area of Science:
- Infectious Diseases
- Clinical Pharmacy
- Healthcare Management
Background:
- Outpatient parenteral antimicrobial therapy (OPAT) requires careful management to ensure efficacy and safety.
- Establishing structured programs can optimize patient care and resource utilization.
Purpose of the Study:
- To describe the development and implementation of a pharmacist-managed OPAT program at a county teaching hospital.
- To outline the key components and pharmacist's role in managing OPAT patients.
Main Methods:
- Conducted a needs assessment to identify program requirements.
- Defined patient selection criteria and developed a care algorithm.
- Established a collaborative agreement between pharmacists and infectious diseases physicians.
Main Results:
- The program involved consistent evaluation, approval, and monitoring of patients on OPAT.
- Pharmacists played a key role in regimen selection, order confirmation, and safety surveillance.
- Structured monitoring and follow-up were implemented for all OPAT patients.
Conclusions:
- The pharmacist-managed OPAT program successfully provided consistent patient oversight.
- The program led to improved patient outcomes and reduced adverse events.
- Implementation demonstrated the value of pharmacist involvement in OPAT services.
More Related Videos
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetics in Pediatric Patients: Drug Excretion
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Methods of Documentation II: POMR

